Given the recent pooled analysis of STARS and ROSEL trials, can we say SBRT for early stage NSCLC is equivalent to lobectomy based on level 1 evidence?  

Will the NCCN guidelines change based on this study?



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice